Mendra, Inc.

Private

San Francisco, CaliforniaHealthcare & Life Scienceshttps://mendra.com/

Last Round

Series A

Jan 21, 2026

Total Funding Raised

$164M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Mendra, Inc. is a biopharmaceutical company that acquires, develops, and commercializes therapies for rare diseases using artificial intelligence.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Medical AI, Drug Discovery, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

rare disease therapeuticsbiopharmaceuticaldrug developmentclinical trial enrollmentpatient identificationAI-enabled drug discoverybiotechasset acquisitionhealthcare analyticsCDMOcontract developmentdrug commercializationAI-first biotechorphan drug developmentpharma tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Mendra, Inc. Comps

Public and private peers based on sector, stage, and business model.

Mendra, Inc. comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Mendra, Inc. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Jan 21, 2026
Series A	Jan 21, 2026

View all Funding Rounds

Key People

Founding team and executive leadership

Lalarukh Haris Shaikh

Co-founder CTO

Founding Team

Mendra, Inc. Investors

Notable investors and investment history

Mendra, Inc. investors
Investor	Rounds
OrbiMed	Series A
5AM Ventures	Series A
Lux Capital	Series A
Wing Venture Capital	Series A
8VC	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

May 16, 2026
Grew 80% QoQ, from 5 to 9 employees.

View all signals

Mendra, Inc. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Mendra, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Mendra, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California

Employee Range9

Year Founded2026

Last FundingJan 21, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.